Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- 16 April 2008
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 453 (7193), 410-414
- https://doi.org/10.1038/nature06868
Abstract
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.Keywords
This publication has 27 references indexed in Scilit:
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapyNature Medicine, 2008
- Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical ModelCancer Research, 2007
- PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survivalNature, 2005
- Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularizationBlood, 2005
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- Mini‐review: Overcoming tumor‐intrinsic resistance to immune effector functionEuropean Journal of Immunology, 2004
- Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in TumorsThe American Journal of Pathology, 2002
- Transformation of the microvascular system during multistage tumorigenesisInternational Journal of Cancer, 2002
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJCI Insight, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996